Assessing drug treatment preferences of patients with Crohn's disease: A conjoint analysis

Patient

Volumn 3, Issue 2, 2010, Pages 113-123

  Lichtenstein, Gary R ^a   Waters, Heidi C ^b   Kelly, Jenna ^b   McDonald, Susan S ^c   Zanutto, Elaine L ^c   Hendricks, David ^b   Rahman, Mirza I ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

^c National Analysts   (United States)

Author keywords

Adalimumab; Conjoint analysis; Crohns disease; Infliximab; Patient preference; Therapeutic use; Treatment; Tumour necrosis factor inhibitors

Indexed keywords

GASTROINTESTINAL AGENT;

ADULT; ANAMNESIS; ARTICLE; BIOLOGICAL THERAPY; CROHN DISEASE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; TWO TAILED TEST; UNITED STATES;

EID: 77953435578     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11314880-000000000-00000     Document Type: Article

References (45)

1. Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in populationbased patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16 (1): 51-60 (Pubitemid 34123864)
2. Loftus Jr EV, Silverstein MD, Sandborn WJ, et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114 (6): 1161-1168
3. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. N Engl J Med 1996; 334 (22): 1441-1447
4. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 2005; 32 (5): 913-919 (Pubitemid 40676504)
5. Sherbourne CD, Hays RD, Ordway L, et al. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J BehavMed 1992; 15 (5): 447-468
6. Johnson FR, Ozdemir S, Mansfield C, et al. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology 2007; 133 (3): 769-779 (Pubitemid 47374126)
7. Johnson FR, Ozdemir S, Mansfield C, et al. Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Anal 2009; 29 (1): 121-136
8. Hauber AB, Johnson FR, Sauriol L, et al. Risking health to avoid injections: preferences of Canadians with type 2 diabetes. Diabetes Care 2005; 28 (9): 2243-2245 (Pubitemid 41242477)
9. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 1997; 20 (3): 292-298
10. Sandborn WJ, Feagan BG, Lichtenstein GR. Medical management of mild to moderate Crohn's disease: evidencebased treatment algorithms for induction and maintenance of remission.Aliment Pharmacol Ther 2007; 26 (7): 987-1003
11. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35 (3): 360-362 (Pubitemid 24092906)
12. Steinhart H. Maintenance therapy in Crohn's disease. Can J Gastroenterol 2000; 14 Suppl. C: 23-8C
13. PresentDH,Korelitz BI,Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study. N Engl J Med 1980; 302 (18): 981-987 (Pubitemid 10125406)
14. Remicade: package insert. Malvern (PA): Centocor, Inc., 2007
15. Humira: package insert. Abbott Park (IL): Abbott Laboratories, 2006
16. Cross RK, Lapshin O, Finkelstein J. Patient subjective assessment of drug side effects in inflammatory bowel disease. J Clin Gastroenterol 2008; 42 (3): 244-251 (Pubitemid 351301488)
17. Eisen GM, Locke III GR, Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol 1999; 94 (8): 2017-2021 (Pubitemid 29374526)
18. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006; 23 (5): 577-585
19. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007; 102 (7): 1417-1426 (Pubitemid 46976288)
20. Kane SV. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs 2008; 68 (18): 2601-2609
21. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther 2002; 16 (9): 1603-1609
22. Green PE, Srinivasan V. Conjoint analysis in marketing: new developments with implications for research and practice. J Marketing 1990; 54: 3-19
23. Blankenship AB, Breen BE, Dutka AF. State of the art marketing research. Chicago (IL): NTC Business Books, 1998
24. Orme BK. Helping managers understand the value of conjoint analysis. In: Orme BK. Getting started with conjoint analysis: strategies for product design and pricing research. Madison (WI): Research Publishers, LLC, 2006: 17-24
25. Kuhfeld WF. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques. Cary (NC): SAS Institute, Inc., 2005
26. Zwerina K, Huber J, Kuhfeld WF. A general method for constructing efficient choice designs. Cary (NC): SAS Institute, Inc., 1996
27. Rossi PE, Gilula Z, Allenby GM. Overcoming scale usage heterogeneity: a Bayesian hierarchical approach. J Am Stat Assoc 2001; 96: 20-31 (Pubitemid 33240627)
28. Allenby GM, Rossi PE. Marketing models of consumer heterogeneity. J Economet 1999; 18: 57-78
29. Orme BK. Hierarchical Bayes: why all the attention? Sequim (WA): Sawtooth Software, Inc., 2000
30. Byrne CM, Solomon MJ, Young JM, et al. Patient preferences between surgical and medical treatment in Crohn's disease. Dis Colon Rectum 2007; 50 (5): 586-597 (Pubitemid 46870467)
31. Braddock III CH, Edwards KA, Hasenberg NM, et al. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999; 282 (24): 2313-2320
32. Braddock III CH, Fihn SD, Levinson W, et al. How doctors and patients discuss routine clinical decisions: informed decision making in the outpatient setting. J Gen Intern Med 1997; 12 (6): 339-345 (Pubitemid 27255387)
33. Waitzkin H. Doctor-patient communication: clinical implications of social scientific research. JAMA1984; 252 (17): 2441-2446 (Pubitemid 14021854)
34. Montgomery AA, Fahey T. How do patients' treatment preferences compare with those of clinicians? Qual Health Care 2001; 10 Suppl. 1: i39-43 (Pubitemid 32844127)
35. BrazierM. Patient autonomy and consent to treatment: the role of the law? Leg Stud (Soc Leg Scholars) 1987; 7 (2): 169-193
36. Quill TE, Brody H. Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med 1996; 125 (9): 763-769 (Pubitemid 126450365)
37. Hickson GB, Clayton EW, Entman SS, et al. Obstetricians' prior malpractice experience and patients' satisfaction with care. JAMA 1994; 272 (20): 1583-1587
38. Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med 2001; 52 (12): 1865-1878 (Pubitemid 32463336)
39. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003; 98 (7): 1535-1544 (Pubitemid 36875345)
40. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ 1999; 319 (7212): 766-771 (Pubitemid 29431536)
41. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26 (5): 331-342 (Pubitemid 32989555)
42. Brody DS, Miller SM, Lerman CE, et al. The relationship between patients' satisfaction with their physicians and perceptions about interventions they desired and received. Med Care 1989; 27 (11): 1027-1035
43. Golin C, DiMatteo MR, Duan N, et al. Impoverished diabetic patients whose doctors facilitate their participation in medical decision making are more satisfied with their care. J Gen Intern Med 2002; 17 (11): 866-875 (Pubitemid 35370552)
44. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention: a suggested approach from the US Preventive Services Task Force. Am J Prev Med 2004; 26 (1): 56-66
45. StewartM, Brown JB,Donner A, et al. The impact of patientcentered care on outcomes. J FamPract 2000; 49 (9): 796-804